The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkey

dc.contributor.authorOzturk, Savas
dc.contributor.authorTurgutalp, Kenan
dc.contributor.authorArici, Mustafa
dc.contributor.authorGorgulu, Numan
dc.contributor.authorTonbul, Halil Zeki
dc.contributor.authorEren, Necmi
dc.contributor.authorGencer, Vedat
dc.date.accessioned2024-02-23T14:02:46Z
dc.date.available2024-02-23T14:02:46Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractIntroduction: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.Methods: We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID-19 group.Results: A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID-19 group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. The 28th-day mortality and mortality between 28th day and 90th day were higher in the COVID-19 group than non-COVID-19 group (19 [3.0%] patients vs. none [0%]; 15 [2.4%] patients vs. 4 [0.7%] patients, respectively). The presence of respiratory symptoms, rehospitalization, need for home oxygen therapy, lower respiratory tract infection, and arteriovenous (AV) fistula thrombosis was significantly higher in the COVID-19 group in both the first 28 days and between 28 and 90 days. In the multivariable analysis, age (odds ratio [OR] [95% CI]: 1.029 [1.004-1.056]), group (COVID-19 group vs. non-COVID-19 group) (OR [95% CI]: 7.258 [2.538-20.751]), and vascular access type (tunneled catheter/AV fistula) (OR [95% CI]: 2.512 [1.249-5.051]) were found as independent parameters related to 90-day mortality.Conclusion: In the post-COVID-19 period, maintenance HD patients who have had COVID-19 have increased rehospitalization, respiratory problems, vascular access problems, and high mortality compared with the non-COVID-19 HD patients.en_US
dc.identifier.doi10.1016/j.ekir.2022.03.017
dc.identifier.endpage1405en_US
dc.identifier.issn2468-0249
dc.identifier.issue6en_US
dc.identifier.pmid35350104en_US
dc.identifier.scopus2-s2.0-85128168000en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1393en_US
dc.identifier.urihttps://doi.org/10.1016/j.ekir.2022.03.017
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11840
dc.identifier.volume7en_US
dc.identifier.wosWOS:000836322100008en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofKidney International Reportsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19en_US
dc.subjectHemodialysisen_US
dc.subjectNationwide Studyen_US
dc.subjectOutcomeen_US
dc.titleThe Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkeyen_US
dc.typeArticleen_US

Dosyalar